A steroid drug long given to treat the facial paralysis of Bell's palsy improves the rate of recovery, but the antivirus drug acyclovir does not, researchers reported Wednesday.
Bell's palsy, which affects the nerve feeding the facial muscles, is relatively rare. In affects up to one in 2,500 people per year, stripping the smile of its symmetry and robbing the eye of its ability to close.
